sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> cytotoxic drugs market

report

Cytotoxic Drugs Market, by Drug Types (Antimetabolites, Alkylating Agents, Vinca Alkaloids, Epipodophyllo Toxins, Taxanes, Camptothecin Analogues, Miscellaneous), Route of Administration (Intravenous, Oral), Distribution Channels (Retail Pharmacies, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC248 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the cytotoxic drugs market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the cytotoxic drugs market. The scope of this report covers the cytotoxic drugs market by its major segments, which include the types, routes of administration, distribution channels, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The increasing applications of cytotoxic drugs in cancer treatment and the growing prevalence of cancer globally have lead to the rise in demand for the cytotoxic drugs market.
  • Also, launches of innovative products and the rapid developments of novel therapeutic modalities are expected to drive the demand for the cytotoxic drugs in the forecast period.
  • However, severe side effects associated with the use of the cytotoxic drugs are restraining the market growth during the study period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s cytotoxic drugs market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

Cytotoxic Drugs Market

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the cytotoxic drugs market by the following segments:

  • Cytotoxic Drugs Market, by Drug Types
    • Antimetabolites
    • Alkylating Agents
    • Vinca Alkaloids
    • Epipodophyllo Toxin
    • Taxanes
    • Camptothecin Analogues
    • Miscellaneous
  • Cytotoxic Drugs Market, by Route of Administrations
    • Intravenous
    • Oral
  • Cytotoxic Drugs Market, by Distribution Channels
    • Retail Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

KEY MARKET PLAYERS

Key players in the cytotoxic drugs market include:

  • Eli Lilly and Company
  • Sanofi
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Celgene Corporation
  • Amgen Inc.
  • Novartis AG
  • Merck
  • Johnson and Johnson
  • GlaxoSmithKline plc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Cytotoxic Drugs Market

TRENDING RELATED REPORT


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. CYTOTOXIC DRUGS MARKET, BY DRUG TYPES
    1. Segment Share
    2. Drug Types
      1. Antimetabolites
      2. Alkylating Agents
      3. Vinca Alkaloids
      4. Epipodophyllo Toxin
      5. Taxanes
      6. Camptothecin Analogues
      7. Miscellaneous
  6. CYTOTOXIC DRUGS MARKET, BY ROUTE OF ADMINISTRATIONS
    1. Segment Share
    2. Route of Administration
      1. Intravenous
      2. Oral
  7. CYTOTOXIC DRUGS MARKET, BY DISTRIBUTION CHANNELS
    1. Segment Share
    2. Distribution Channels
      1. Retail Pharmacies
      2. Hospital Pharmacies
      3. Retail Pharmacies
      4. Online Pharmacies
  8. CYTOTOXIC DRUGS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Drug Types
      3. By Route of Administrations
      4. By Distribution Channels
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Drug Types
      3. By Route of Administrations
      4. By Distribution Channels
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Drug Types
      3. By Route of Administrations
      4. By Distribution Channels
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Drug Types
      3. By Route of Administrations
      4. By Distribution Channels
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Sanofi
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Celgene Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Amgen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Merck
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Johnson and Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us